J2810 HCPCS code: Injection, theophylline, per 40 mg
J2810 is the HCPCS Level II code for injection, theophylline, per 40 mg. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 20 per day on outpatient hospital claims.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 1997-01-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 20 | Clinical: Data |
| practitioner claims | 5 | Clinical: Data |
What changed for J2810
- 1982-01-01: J2810 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2810?
J2810 is the HCPCS Level II code for injection, theophylline, per 40 mg. Short descriptor: "Inj theophylline per 40 mg".
Does Medicare cover J2810?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J2810 can be billed per day?
20 on outpatient hospital claims; 5 on practitioner claims (NCCI medically unlikely edits).
Related J28 codes
- J2800 — Injection, methocarbamol, up to 10 ml
- J2801 — Injection, risperidone (rykindo), 0.5 mg
- J2802 — Injection, romiplostim, 1 microgram
- J2804 — Injection, rifampin, 1 mg
- J2805 — Injection, sincalide, 5 micrograms
- J2806 — Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms
- J2820 — Injection, sargramostim (gm-csf), 50 mcg
- J2840 — Injection, sebelipase alfa, 1 mg
- J2850 — Injection, secretin, synthetic, human, 1 microgram
- J2860 — Injection, siltuximab, 10 mg
- J2865 — Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2810
- Watch J2810 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2810
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.